Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside
出版年份 2022 全文链接
标题
Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside
作者
关键词
-
出版物
Experimental Hematology & Oncology
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-11-11
DOI
10.1186/s40164-022-00352-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Deglycosylated EpCAM regulates proliferation by enhancing autophagy of breast cancer cells via PI3K/Akt/mTOR pathway
- (2022) Liu Yang et al. Aging-US
- Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior
- (2022) Alba Rodriguez-Martinez et al. Theranostics
- Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer
- (2022) Xinlin Liu et al. PHARMACOLOGY & THERAPEUTICS
- Integrated microfluidic-SERS for exosome biomarker profiling and osteosarcoma diagnosis
- (2022) Zhenzhen Han et al. BIOSENSORS & BIOELECTRONICS
- EpCAM-Mediated Cellular Plasticity Promotes Radiation Resistance and Metastasis in Breast Cancer
- (2021) Arijit Mal et al. Frontiers in Cell and Developmental Biology
- A multimodal molecular imaging approach targeting urokinase plasminogen activator receptor for the diagnosis, resection and surveillance of urothelial cell carcinoma
- (2021) Victor M. Baart et al. EUROPEAN JOURNAL OF CANCER
- Doxorubicin‐induced senescence promotes stemness and tumorigenicity in EpCAM−/CD133− nonstem cell population in hepatocellular carcinoma cell line, HuH‐7
- (2021) Mustafa Karabicici et al. Molecular Oncology
- Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown
- (2021) Ying Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bedaquiline, an FDA-approved drug, inhibits mitochondrial ATP production and metastasis in vivo, by targeting the gamma subunit (ATP5F1C) of the ATP synthase
- (2021) Marco Fiorillo et al. CELL DEATH AND DIFFERENTIATION
- EpCam is Required for Maintaining the Integrity of the Biliary Epithelium
- (2021) Yougen Zhan et al. LIVER INTERNATIONAL
- Trop‐2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis
- (2021) Marco Trerotola et al. NEOPLASIA
- Rapamycin pretreatment rescues the bone marrow AML cell elimination capacity of CAR-T cells
- (2021) Zhigang Nian et al. CLINICAL CANCER RESEARCH
- Development of a recombinant anti-VEGFR2-EPCAM bispecific antibody to improve antiangiogenic efficiency
- (2021) Khadijeh Barzaman et al. EXPERIMENTAL CELL RESEARCH
- Complex Alterations of Fatty Acid Metabolism and Phospholipidome Uncovered in Isolated Colon Cancer Epithelial Cells
- (2021) Jiřina Hofmanová et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ectopic activation of the miR-200c–EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapy
- (2021) Minggang Zhang et al. Science Translational Medicine
- Clinical verification of vimentin/EpCAM immunolipid magnetic sorting system in monitoring CTCs in arterial and venous blood of advanced tumor
- (2021) Yan Liu et al. JOURNAL OF NANOBIOTECHNOLOGY
- Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses
- (2021) Yanping Yang et al. Cancer Immunology Research
- Bispecific antibody CD73xEpCAM selectively inhibits the adenosine-mediated immunosuppressive activity of carcinoma-derived extracellular vesicles
- (2021) Emily M. Ploeg et al. CANCER LETTERS
- Trop2 Forms a Stable Dimer with Significant Structural Differences within the Membrane-Distal Region as Compared to EpCAM
- (2021) Miha Pavšič INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells
- (2021) Shin Yi Tang et al. Stem Cell Research & Therapy
- Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy
- (2021) Weizhen Li et al. Frontiers in Pharmacology
- CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM
- (2021) Guillaume Belthier et al. Cancers
- MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma
- (2020) Laura Gramantieri et al. CANCER RESEARCH
- Detection of circulating tumor cells and their implications as a novel biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma
- (2020) Joseph C Ahn et al. HEPATOLOGY
- The heparan sulfate proteoglycan syndecan‐1 regulates colon cancer stem cell function via a focal adhesion kinase—Wnt signaling axis
- (2020) Sampath Kumar Katakam et al. FEBS Journal
- Hyaluronic acid induction on breast cancer stem cells unfolds subtype specific variations in stemness and epithelial-to-mesenchymal transition
- (2020) Heena Jariyal et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- T cell-engaging therapies — BiTEs and beyond
- (2020) Maria-Elisabeth Goebeler et al. Nature Reviews Clinical Oncology
- EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1
- (2020) Dong Jun Park et al. Journal for ImmunoTherapy of Cancer
- Matriptase Cleaves EpCAM and TROP2 in Keratinocytes, Destabilizing Both Proteins and Associated Claudins
- (2020) Chuan-Jin Wu et al. Cells
- Cytoplasmic expression of B7-H3 and membranous EpCAM expression are associated with higher grade and survival outcomes in patients with clear cell renal cell carcinoma
- (2020) Leili Saeednejad Zanjani et al. Annals of Diagnostic Pathology
- EpCAM signaling promotes tumor progression and protein stability of PD-L1 through the EGFR pathway
- (2020) Hao-Nien Chen et al. CANCER RESEARCH
- Chemotherapeutic resistance of head and neck squamous cell carcinoma is mediated by EpCAM induction driven by IL-6/p62 associated Nrf2-antioxidant pathway activation
- (2020) Abu Shadat M. Noman et al. Cell Death & Disease
- Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape
- (2020) Elena Shramova et al. Cancers
- EpCAM cellular functions in adhesion and migration, and potential impact on invasion: A critical review
- (2020) François Fagotto et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Downregulation of cytokeratin 18 induces cellular partial EMT and stemness through increasing EpCAM expression in breast cancer
- (2020) Ruizan Shi et al. CELLULAR SIGNALLING
- Histone demethylase JMJD2D promotes the self-renewal of liver cancer stem-like cells by enhancing EpCAM and Sox9 expression
- (2020) Yuan Deng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Outlook for New CAR-Based Therapies with a Focus on CAR NK Cells: What Lies Beyond CAR-Engineered T Cells in the Race against Cancer
- (2020) May Daher et al. Cancer Discovery
- Membrane-associated epithelial cell adhesion molecule is slowly cleaved by γ-secretase prior to efficient proteasomal degradation of its intracellular domain
- (2019) Yuanchi Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The role and molecular mechanism of Trop2 induced epithelial-mesenchymal transition through mediated β-catenin in gastric cancer
- (2019) Wei Zhao et al. Cancer Medicine
- Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release
- (2019) Shu Lian et al. EBioMedicine
- MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM
- (2019) Jessica B. Casaletto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genome-wide RNAi Screen identifies PMPCB as a therapeutic vulnerability in EpCAM+ hepatocellular carcinoma
- (2019) Atsushi Takai et al. CANCER RESEARCH
- The extracellular domain of epithelial cell adhesion molecule (EpCAM) enhances multipotency of mesenchymal stem cells through EGFR–LIN28–LET7 signaling
- (2019) I.-I. Kuan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of Tumor Specific Peptide as EpCAM Ligand and Its Potential Diagnostic and Therapeutic Clinical Application
- (2019) Xiaowen Ma et al. MOLECULAR PHARMACEUTICS
- Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines
- (2019) Tataranni et al. Cells
- Monitoring of cancer patients via next‐generation sequencing of patient‐derived circulating tumor cells and tumor DNA
- (2019) Kaoru Onidani et al. CANCER SCIENCE
- miR‐26b‐5p helps in EpCAM+cancer stem cells maintenance via HSC71/HSPA8 and augments malignant features in HCC
- (2019) Ritu Khosla et al. LIVER INTERNATIONAL
- Immunocyte Profiling Using Single-Cell Mass Cytometry Reveals EpCAM+ CD4+ T Cells Abnormal in Colon Cancer
- (2019) Ting Zhang et al. Frontiers in Immunology
- Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and stemness-related subpopulations in liver cancer
- (2019) Daniel Wai-Hung Ho et al. CANCER LETTERS
- Profiling of Exosomal Biomarkers for Accurate Cancer Identification: Combining DNA‐PAINT with Machine‐ Learning‐Based Classification
- (2019) Chen Chen et al. Small
- Hypoxia modulates stem cell properties and induces EMT through N ‐glycosylation of EpCAM in breast cancer cells
- (2019) Dandan Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- TGF-β1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p
- (2019) Ke-shuai Dong et al. ONCOGENE
- LncRNATCF7 promotes the growth and self-renewal of glioma cells via suppressing the miR-200c-EpCAM axis
- (2018) Jian Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- Quantified postsurgical small cell size CTCs and EpCAM + circulating tumor stem cells with cytogenetic abnormalities in hepatocellular carcinoma patients determine cancer relapse
- (2018) Liang Wang et al. CANCER LETTERS
- Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells
- (2018) Kang-Hao Liang et al. CANCER LETTERS
- Antibody based EpCAM targeted Therapy of Cancer, Review and update
- (2018) Shirin Eyvazi et al. CURRENT CANCER DRUG TARGETS
- The role of EpCAM in tumor progression and the clinical prognosis of endometrial carcinoma
- (2018) Kuo-Chang Wen et al. GYNECOLOGIC ONCOLOGY
- A Novel Multimarker Assay for the Phenotypic Profiling of Circulating Tumor Cells in Hepatocellular Carcinoma
- (2018) Colin M. Court et al. LIVER TRANSPLANTATION
- Extracellular vesicles in cancer — implications for future improvements in cancer care
- (2018) Rong Xu et al. Nature Reviews Clinical Oncology
- Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM+CD45+ phenotype
- (2018) Md Zahid Akhter et al. ONCOGENE
- Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway
- (2018) Meng-He Wang et al. Cell Death & Disease
- EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs
- (2018) Joanna Macdonald et al. Cancers
- Deglycosylation of epithelial cell adhesion molecule affects epithelial to mesenchymal transition in breast cancer cells
- (2018) Xue Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Regulation of epithelial migration by epithelial cell adhesion molecule requires its Claudin-7 interaction domain
- (2018) Angela I. M. Barth et al. PLoS One
- EpCAM homo-oligomerization is not the basis for its role in cell-cell adhesion
- (2018) Aljaž Gaber et al. Scientific Reports
- EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers
- (2018) Min Pan et al. PLOS BIOLOGY
- Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo
- (2018) Jie Ni et al. BMC CANCER
- NK cell-derived IFN-γ promotes hepatocellular carcinoma through EpCAM-EMT axis in hepatitis B virus transgenic mice
- (2018) Yongyan Chen et al. HEPATOLOGY
- Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
- (2018) Qing Zhang et al. Journal of Immunology Research
- Long non-coding RNA THOR promotes liver cancer stem cells expansion via β-catenin pathway
- (2018) Zhangjun Cheng et al. GENE
- Matriptase-mediated cleavage of EpCAM destabilizes claudins and dysregulates intestinal epithelial homeostasis
- (2017) Chuan-Jin Wu et al. JOURNAL OF CLINICAL INVESTIGATION
- Hedgehog signaling pathway affects the sensitivity of hepatoma cells to drug therapy through the ABCC1 transporter
- (2017) Jia Ding et al. LABORATORY INVESTIGATION
- A double-negative feedback loop between EpCAM and ERK contributes to the regulation of epithelial–mesenchymal transition in cancer
- (2017) N V Sankpal et al. ONCOGENE
- Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
- (2017) Dongxi Xiang et al. Theranostics
- Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth
- (2017) Jingying Zheng et al. Theranostics
- EpCAM+ Liver Cancer Stem-Like Cells Exhibiting Autocrine Wnt Signaling Potentially Originate in Cirrhotic Patients
- (2017) Ritu Khosla et al. Stem Cells Translational Medicine
- EpEX/EpCAM and Oct4 or Klf4 alone are sufficient to generate induced pluripotent stem cells through STAT3 and HIF2α
- (2017) I.-I. Kuan et al. Scientific Reports
- p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signaling
- (2016) Nikhil Tyagi et al. CANCER LETTERS
- EpCAM Inhibition Sensitizes Chemoresistant Leukemia to Immune Surveillance
- (2016) Xiaohu Zheng et al. CANCER RESEARCH
- Epigenetic Switch between SOX2 and SOX9 Regulates Cancer Cell Plasticity
- (2016) Sheng-Chieh Lin et al. CANCER RESEARCH
- EpCAM-Regulated Transcription Exerts Influences on Nanomechanical Properties of Endometrial Cancer Cells That Promote Epithelial-to-Mesenchymal Transition
- (2016) Ya-Ting Hsu et al. CANCER RESEARCH
- Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis
- (2016) Xue Wang et al. JOURNAL OF HEPATOLOGY
- Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization
- (2016) Hyungjin Rhee et al. MODERN PATHOLOGY
- A New Class of Antibody-Drug Conjugates with Potent DNA Alkylating Activity
- (2016) M. L. Miller et al. MOLECULAR CANCER THERAPEUTICS
- Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker
- (2016) Joerg U Schmohl et al. MOLECULAR THERAPY
- Nuclear EpICD expression and its role in hepatocellular carcinoma
- (2016) SHIN YOUNG PARK et al. ONCOLOGY REPORTS
- EpCAM-dependent extracellular vesicles from intestinal epithelial cells maintain intestinal tract immune balance
- (2016) Lingling Jiang et al. Nature Communications
- EpCAM is up-regulated by EGF via ERK1/2 signaling and suppresses human epithelial ovarian cancer cell migration
- (2015) Qianlan Fan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- PLK1 and HOTAIR Accelerate Proteasomal Degradation of SUZ12 and ZNF198 during Hepatitis B Virus–Induced Liver Carcinogenesis
- (2015) Hao Zhang et al. CANCER RESEARCH
- βII-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin
- (2015) Xiuling Zhi et al. HEPATOLOGY
- Cleavage and Cell Adhesion Properties of Human Epithelial Cell Adhesion Molecule (HEPCAM)
- (2015) Thanos Tsaktanis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro
- (2015) Francesca Ferrari et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Interrogating Circulating Microsomes and Exosomes Using Metal Nanoparticles
- (2015) Yi-Ge Zhou et al. Small
- The detection of EpCAM+ and EpCAM– circulating tumor cells
- (2015) Sanne de Wit et al. Scientific Reports
- EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer
- (2015) Helen Schneck et al. PLoS One
- The Role of Relative Lymphocyte Count as a Biomarker for the Effect of Catumaxomab on Survival in Malignant Ascites Patients: Results from a Phase II/III Study
- (2014) M. M. Heiss et al. CLINICAL CANCER RESEARCH
- Bispecific T-cell engagers for cancer immunotherapy
- (2014) Amelia M Huehls et al. IMMUNOLOGY AND CELL BIOLOGY
- Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway
- (2014) Z.J. LIAO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Epithelial-to-Mesenchymal Transition Induced by TGF-β1 Is Mediated by AP1-Dependent EpCAM Expression in MCF-7 Cells
- (2014) Jiujiao Gao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer
- (2014) Hannah Woopen et al. Journal of Gynecologic Oncology
- E-Cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin αvβ6 and maintained through TGFβ signalling
- (2014) C Eberlein et al. ONCOGENE
- Crystal structure and its bearing towards an understanding of key biological functions of EpCAM
- (2014) Miha Pavšič et al. Nature Communications
- A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors
- (2013) Joseph P Connor et al. BMC CANCER
- Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis
- (2013) V S Warneke et al. BRITISH JOURNAL OF CANCER
- Heterodimeric Bispecific Single-Chain Variable-Fragment Antibodies Against EpCAM and CD16 Induce Effective Antibody-Dependent Cellular Cytotoxicity Against Human Carcinoma Cells
- (2013) Daniel A. Vallera et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- An EpCAM/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression
- (2013) Pengfei Zhang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Trop-2 Promotes Prostate Cancer Metastasis By Modulating 1 Integrin Functions
- (2013) M. Trerotola et al. CANCER RESEARCH
- Promoter Hypomethylation of EpCAM-Regulated Bone Morphogenetic Protein Gene Family in Recurrent Endometrial Cancer
- (2013) Y.-T. Hsu et al. CLINICAL CANCER RESEARCH
- EpCAM Controls Actomyosin Contractility and Cell Adhesion by Direct Inhibition of PKC
- (2013) Nadim Maghzal et al. DEVELOPMENTAL CELL
- Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway
- (2013) Jie Ni et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Epithelial Cell Adhesion Molecule (EpCAM) Regulates Claudin Dynamics and Tight Junctions
- (2013) Chuan-Jin Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth
- (2013) Agnieszka Martowicz et al. Molecular Cancer
- EpCAM Modulates NF-κB Signaling and Interleukin-8 Expression in Breast Cancer
- (2013) Narendra V. Sankpal et al. MOLECULAR CANCER RESEARCH
- Context-dependent adaption of EpCAM expression in early systemic esophageal cancer
- (2013) C Driemel et al. ONCOGENE
- Regulated Intramembrane Proteolysis and Degradation of Murine Epithelial Cell Adhesion Molecule mEpCAM
- (2013) Matthias Hachmeister et al. PLoS One
- Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
- (2013) E. A. Akbay et al. Cancer Discovery
- Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer
- (2012) M. Schmidt et al. ANNALS OF ONCOLOGY
- EpCAM contributes to formation of functional tight junction in the intestinal epithelium by recruiting claudin proteins
- (2012) Zili Lei et al. DEVELOPMENTAL BIOLOGY
- Catumaxomab
- (2012) James E. Frampton DRUGS
- Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via -catenin signaling
- (2012) T. Stoyanova et al. GENES & DEVELOPMENT
- Epithelial Cell Adhesion Molecule Regulates Tumor Initiation and Tumorigenesis via Activating Reprogramming Factors and Epithelial-Mesenchymal Transition Gene Expression in Colon Cancer
- (2012) Cheng-Wei Lin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Therapeutic Potential of Amanitin-Conjugated Anti-Epithelial Cell Adhesion Molecule Monoclonal Antibody Against Pancreatic Carcinoma
- (2012) Gerhard Moldenhauer et al. JNCI-Journal of the National Cancer Institute
- EpCAM regulates cell cycle progression via control of cyclin D1 expression
- (2012) A Chaves-Pérez et al. ONCOGENE
- Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells
- (2011) Takeshi Motohara et al. CARCINOGENESIS
- EpCAM/CD3-Bispecific T-cell Engaging Antibody MT110 Eliminates Primary Human Pancreatic Cancer Stem Cells
- (2011) M. Cioffi et al. CLINICAL CANCER RESEARCH
- Epithelial Cell Adhesion Molecule (EpCAM) Complex Proteins Promote Transcription Factor-mediated Pluripotency Reprogramming
- (2011) Hsiang-Po Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis
- (2010) Ranju Ralhan et al. BMC CANCER
- Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies
- (2010) Markus Münz et al. Cancer Cell International
- Angiogenesis and clinicopathologic characteristics in different hepatocellular carcinoma subtypes defined by EpCAM and α-fetoprotein expression status
- (2010) Yun-feng Shan et al. MEDICAL ONCOLOGY
- Phase II Study of the Human Anti-Epithelial Cell Adhesion Molecule Antibody Adecatumumab in Prostate Cancer Patients with Increasing Serum Levels of Prostate-Specific Antigen after Radical Prostatectomy
- (2010) Norbert Marschner et al. UROLOGIA INTERNATIONALIS
- An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer
- (2009) M. Schmidt et al. ANNALS OF ONCOLOGY
- Initial activation of EpCAM cleavage viacell-to-cell contact
- (2009) Sabine Denzel et al. BMC CANCER
- Preclinical Assessment of an Anti-EpCAM Immunotoxin: Locoregional Delivery Provides a Safer Alternative to Systemic Administration
- (2009) Jennifer Brown et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Transcriptional Repression of Epithelial Cell Adhesion Molecule Contributes to p53 Control of Breast Cancer Invasion
- (2009) N. V. Sankpal et al. CANCER RESEARCH
- The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
- (2009) M. Munz et al. CANCER RESEARCH
- Radiofrequency Ablation Combined with KS-IL2 Immunocytokine (EMD 273066) Results in an Enhanced Antitumor Effect against Murine Colon Adenocarcinoma
- (2009) E. E. Johnson et al. CLINICAL CANCER RESEARCH
- Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin
- (2009) Jeannick Cizeau et al. JOURNAL OF IMMUNOTHERAPY
- Nuclear signalling by tumour-associated antigen EpCAM
- (2009) Dorothea Maetzel et al. NATURE CELL BIOLOGY
- Characterization of Epithelial Cell Adhesion Molecule as a Surface Marker on Undifferentiated Human Embryonic Stem Cells
- (2009) Valerie Y. Ng et al. STEM CELLS
- Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM
- (2008) Markus Munz Frontiers in Bioscience-Landmark
- Identification of EpCAM as the Gene for Congenital Tufting Enteropathy
- (2008) Mamata Sivagnanam et al. GASTROENTEROLOGY
- EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
- (2008) Taro Yamashita et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now